Eli Lilly (LLY) Stock Soars as Analysts Boost Price Targets on Weight Loss Drug Momentum

Eli Lilly (LLY) stock rallies as JPMorgan sets $1,400 target and RBC hits $1,500, fueled by booming Mounjaro and Zepbound sales and Medicare expansion.

The post Eli Lilly (LLY) Stock Soars as Analysts Boost Price Targets on Weight Loss Drug Momentum appeared first on Blockonomi.